Shuttle Pharmaceuticals Inc (SHPH) — Strategic Asset Allocation Index
Shuttle Pharmaceuticals Inc (SHPH) has a Strategic Asset Allocation Index of 0.7% as of March 2023. Strategic assets (PP&E of $50.93K plus long-term investments of $-) total $50.93K, measured against net assets of $6.91 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Shuttle Pharmaceuticals Inc Strategic Asset Allocation Index (2018–2022)
This chart shows how Shuttle Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2018 to 2022. As of March 2023, the index stands at 0.7%, representing strategic assets of $50.93K against net assets of $6.91 Million USD. Explore Shuttle Pharmaceuticals Inc (SHPH) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Shuttle Pharmaceuticals Inc (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Shuttle Pharmaceuticals Inc from 2018 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Shuttle Pharmaceuticals Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.9% | $68.71K | $68.71K | $- | $7.68 Million | ▼ -2.2 pp |
| 2018 | 3.1% | $838.00 | $838.00 | $- | $27.46K | — |